Agencies should not submit a discharge OASIS in the event of a single visit in a quality episode, according to updated guidance from CMS in the July 2023 CMS Quarterly OASIS Q&As, released Tuesday.
These instructions supersede previously published guidance that just stated the discharge OASIS was “not required” in the situation of a single visit quality episode.
The quarterly Q&A includes seven responses, including what an agency should do if an OASAS reviewer has questions about an OASIS, but the clinician is no longer with the agency.
CMS notes that errors that can be validated — with documentation — can be corrected. But a discrepancy between two data items without knowing which is correct cannot be changed and should be submitted with the original responses.
“The comprehensive assessment, including the OASIS, is a legal document and when signed by a clinician, the signature is an attestation that all information contained in the document is truthful and accurate,” CMS states.